Genetic, Clinical, and Radiographic Delineation of Hallervorden-Spatz Syndrome
NEJM 348:33-40, Hayflick,S.J.,et al, 2003

Does This Patient Have Parkinson Disease?
JAMA 289:347-353, Rao,G.,et al, 2003

Analysis of Pooled Data From the Randomised Controlled Trials of Endarterectomy for Symptomatic Carotid Stenosis
Lancet 361:107-116, Rothwell,P.M.,et al, 2003

An Unconsious Girl with Sickle-Cell Disease
Lancet 361:136, van Mierlo,T.D.,et al, 2003

Central Nervous System Paracoccidioidomycosis: Imaging Findings in 17 Cases
J Comput Assist Tomogr 27:12-17, Gasparetto,E.L.,et al, 2003

Rapidly Reversible Dementia
Lancet 361:392, Bernstein,R.,et al, 2003

Efficacy of IV Tisuse Plasminogen Activator in Acute Stroke
Neurol 61:71-75, Hsia,A.W.,et al, 2003

For Severe Carotid Stenosis Found on Ultrasound, Further Arterial Evaluation is Unnecessary
Stroke 34:1816-1817,1819, Moore,W.S., 2003

For Severe Carotid Stenosis Found on Ultrasound, Further Arterial Evaluation Prior to Carotid Endarterectomy Is Unnecessary: The Argument Against
Stroke 34:1817-1819, Rothwell,P.M., 2003

Clinical Manifestations of Sarin Nerve Gas Exposure
JAMA 290:659-662, Lee,E.C., 2003

Trial Design and Reporting Standards for Intra-Arterial Cerebral Thrombolysis for Acute Ischemic Stroke
Stroke 34:1923-1924, Higashida,R.T.,et al, 2003

Neurologic Manifestations and Outcome of West Nile Virus Infection
JAMA 290:511-515,524,558, Sejvar,J.J.,et al, 2003

Cavernous Sinus Syndrome: Clinical Features and Differential Diagnosis with MR Imaging
AJR 181:583-590, Lee,J.H.,et al, 2003

Tinnitus After Cycling
Lancet 362:292, Lanczik,O.,et al, 2003

Advertising Strategies to Increase Public Knowledge of the Warning Signs of Stroke
Stroke 34:1965-1969, Silver,F.L.,et al, 2003

"Computed Tomography-Negative" Intracerebral Hemorrhage
Arch Neurol 60:1156-1159, Packard,A.S.,et al, 2003

Constipation in Neurological Diseases
JNNP 74:13-19, Winge,K.,et al, 2003

Trends in Community Knowledge of the Warning Signs and Risk Factors for Stroke
JAMA 289:343-346, Schneider,A.T.,et al, 2003

Neurologic Manifestations of Lightning Strikes
Neurol 60:182-185, Cherington,M., 2003

Are Some Patients Likely to Benefit From Recombinant Tissue-Type Plasminogen Activator for Acute Ischemic Stroke Even Beyond 3 Hours From Symptom Onset?
Stroke 34:464-467, Kent,D.M.,et al, 2003

Reanalysis of the Final Results of the European Carotid Surgery Trial
Stroke 34:514-523, Rothwell,P.M.,et al, 2003

Imaging-Based Decision Making in Thrombolytic Therapy for Ischemic Stroke
Stroke 34:575-583, Schellinger,P.D.,et al, 2003

CMT with Pyramidal Features
Neurol 60:696-699, Vucic,S.,et al, 2003

Use of a Field-to-Stroke Center Helicopter Transport Program to Extend Thrombolytic Therapy to Rural Residents
Stroke 34:729, Silliman,S.L.,et al, 2003

Telemedicine for Acute Stroke
Stroke 34:725, LaMonte,M.P.,et al, 2003

Early Major Ischemic Changes on Computed Tomography Should Preclude Use of Tissue Plaminogen Activator
Stroke 34:820-821,822, von Kummer,R., 2003

Early Major Ischemic Changes on Computed Tomography Should Not Preclude Use of Tissue Plasminogen Activator
Stroke 34:821-822,822, Lyden,P.,et al, 2003

Vestibular Reflexes and Positional Manoeuvres
JNNP 74:289-293, Bronstein,A.M., 2003

CSF Hypovolemia vs Intracranial Hypotension in "Spontaneous Intracranial Hypotension Syndrome"
Neurol 60:941-947, Miyazawak,K.,et al, 2003

Quantitative Sensory Testing, Report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology
Neurol 60:898-904, Shy,M.E.,et al, 2003

Clinical Features and Natural Histry of Progressive Supranuclear Palsy, A Clinical Cohort Study
Neurol 60:910-916, Nath,W.,et al, 2003

Stem Cells and Neurological Disease
JNNP 74:553-557, Barker,R.A.,et al, 2003

Reappraisal of Early CT signs to Predict the Arterial Occlusion Site in Acute Embolic Stroke
JNNP 74:649-653, Koga,M.,et al, 2003

Vaccinations and Risk of Central Nervous System Demyelinating Diseases in Adults
Arch Neurol 60:504-509, DeStefano,F.,et al, 2003

Cerebellar Ataxia and Coenzyme Q10 Deficiency
Neurol 60:1206-1208, Lamperti,C.,et al, 2003

Cerebral Venous Thrombosis
Neurol 60:1175-1178, Cakmak,S.,et al, 2003

Clinical Features of Headache at Altitude
Neurol 60:1167-1171, Silber,E.,et al, 2003

Guidelines for the Early Management of Patients with Ischemic Stroke
Stroke 34:1056-1083, Adams,H.P.,et al, 2003

Anticoagulation for Cerebral Sinus Thrombosis
Stroke 34:1054-1055, Stam,J.,et al, 2003

Stereotactic Treatment of Intracerebral Hematoma by Means of a Plasminogen Activator
Stroke 34:968-974, Teernstra,O.P.M.,et al, 2003

Cuahoga County Operation Stroke Speed of Emergency Department Evaluation and Compliance with National Institutes of Neurological Disorders and Stroke Time Targets
Stroke 34:994-998, Katzan,I.L.,et al, 2003

Recanalisation of Cerebral Venous Thrombosis
JNNP 74:459-461, Baumgartner,R.W.,et al, 2003

Apoptosis and Caspases in Neurodegenerative Diseases
NEJM 348:1365-1375, Friedlander,R.M., 2003

Frequency of Thrombolytic Therapy in Patients With Acute Ischemic Stroke and the Risk of In-Hospital Mortality
Stroke 34:1106-1113, Heuschmann,P.U.,et al, 2003

Pre- and In-Hospital Delays From Stroke Onset to Intra-arterial Thrombolysis
Stroke 34:1230-1234, Nedeltchev,K.,et al, 2003

Effects of Admission Hyperglycemia on Stroke Outcome in Reperfused Tissue Plasminogen Activator-Treated Patients
Stroke 34:1235-1241, Alvarez-Sabin,J.,et al, 2003

Duplex Ultrasound and Magnetic Resonance Angiography Compared with Digital Subtraction Angiography in Carotid Artery Stenosis
Stroke 34:1324-1332, Nederkoorn,P.J.,et al, 2003

Idiopathic Intracranial Hypertension
Neurol 60:1418-1424,1406, Farb,R.I.,et al, 2003

Hemi-orolingual Angioedema and ACE Inhibition After Alteplase Treatment of Stroke
Neurol 60:1525-1527,1403, Hill,M.D.,et al, 2003

Clinicopath Conf., Brain Abscess Due to Infection with Streptococcus milleri and Haemophilus aphrophilus
NEJM 348:2125-2132, Case 16:2003, 2003